eCTD Submission Strategies: In-house vs. Outsourcing

Webinar: eCTD Submission Different Strategies: In-house vs. Outsourcing

eCTD Submission Strategies, including outsourcing, are influenced by varying requirements in various regions and countries. That and diverse technical resources by companies often lead to various regulatory strategies. Thus, the questions arises: how to choose the best tactics for eCTD submission that your needs?

The purpose of this webinar is to discuss the different approaches to prepare eCTD submissions, its requirements, technical resources, and process validation.

 

You will learn about:

1. Requirements for eCTD

  • Different forms of eCTD used in EU vs. EAEU eCTD
  • Legislation framework
  • Regions and countries following the eCTD

2. Different approaches to prepare eCTD submissions: In-house vs. Outsourcing

3. Technical resources

  • Software and networks
  • Document and project management
  • Potential challenges

4. How to validate submission to achieve compliance and high quality

  • Tips and tricks

 

Who Should Attend? Professionals from the following fields:

  • Regulatory Managers
  • Regulatory Strategy Managers
  • RA Partnerships Operations Manager
  • QA Managers supporting RA
  • RA Healthcare Compliance Managers

 

Duration: 25 min.

Speaker: Head of Global Regulatory Affairs, Olga Bernardova, MSc, who will share her expertise regarding eCTD submissions.

Olga Bernardova, MSc

Olga Bernardova, MSc

Head of Global Regulatory Affairs

Registering a new product?

Make use of our experts to enter new markets. Explore your options in an informal chat with one of our experts.

Other content that might interest you:

Drug Registration in the Eurasian Economic Union (EAEU)

Drug Registration in the Eurasian Economic Union (EAEU)

If you are interested in marketing your medicinal product in the fast-growing pharmaceutical market of the Eurasian Economic Union (EAEU) and if you want to how to apply for market authorization in the EAEU, this blog post is for you. The first part of this article...

read more
Marketing Authorization Renewal in the MENA Region

Marketing Authorization Renewal in the MENA Region

Regulatory Authorities across the MENA region indicate a specific validity period for the Marketing Authorization Approval certificate of pharmaceutical products that ranges between four to five years in most countries. The purpose behind this license validity period...

read more